Определение и способы измерения выраженности ургентности у больных с гиперактивным мочевым пузырем

1. Abrams P, Wein AJ. The overactive bladder: from basic science to clinical management. Urology 1997; 50 (Suppl. 6A): 1–144.
2. Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–36.
3. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760–6.
4. Liberman JN, Hunt TL, Stewart WF et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. communitybased survey. Urology 2001; 57: 1044–50.
5. Zinner N, Noe L, Rasouliyan L et al. Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Curr Med Res Opin 2008 Apr 17.
6. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78.
7. Chapple CR, Artibani W, Cardozo LD et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: Current concepts and future prospects. BJU Int 2005; 95: 335–40.
8. Athwal BS, Berkley KJ, Hussain I et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain 2001; 124: 369–77.
9. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997; 50: 36–52.
10. Drake MJ, Harvey IJ, Gillespie JI et al. Localized contractions in the normal human bladder and in urinary urgency. BJU Int 2005; 95: 1002–5.
11. Turner WH, Brading AF. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol Ther 1997; 75: 77–110.
12. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P et al. New concepts in relation to urge and detrusor activity. Neurourol Urodyn 1993; 12: 463–71.
13. de Groat WC. The urothelium in overactive bladder: Passive bystander or active participant? Urology 2004; 64: 7–11.
14. Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001; 358: 401–3.
15. Brubaker L. Urinary urgency and frequency: What should a clinician do? Obstet Gynecol 2005; 105: 661–7.
16. Greenberg P, Brown J, Yates T et al. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol Urodyn 2008; 27 (4): 287–90.
17. Abrams P. Urgency the key to defining the overactive bladder. BJU Int 2005; 96: 1–3.
18. Barber MD. Questionnaires for women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 461–5.
19. Abrams P, Artibani W, Cardozo L et al. Reviewing the ICS 2002 Terminology Report: The Ongoing Debate. Neurourol Urodyn 2006; 25: 293.
20. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence in Women. November 2001.
21. Cardozo L, Coyne KS, Versi E. Validation of the urgency perception scale. BJU Int 2005; 95: 591–6.
22. Blaivas JG, Panagopoulos G, Weiss JP et al. The urgency perception score: Validation and test–retest. J Urol 2007; 177: 199–202.
23. Blaivas JG, Panagopoulos G, Weiss JP et al. The urgency perception score: Validation and test–retest. J Urol 2007; 177: 199–202.
24. Nixon A, Colman S, Sabounjian L et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005; 174: 604–7.
25. Lukacz ES, Lawrence JM, Burchette RJ et al. The use of Visual Analog Scale in urogynecologic research: A psychometric evaluation. Am J Obstet Gynecol 2004; 191: 165–70.
26. Coyne K, Matza LS, Versi E. Urinary urgency: Can "'gotta go'" be measured? Poster presented at the 10th Annual Meeting of the International Society for Quality of Life Research, Prague, Czech Republic, 2003.
27. Freeman RM. How urgent is urgency? A review of current methods of assessment. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16: 93–5.
28. Zinner N, Harnett M, Sabounjian L et al. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 2005; 173: 1639–43.
29. Yamaguchi O, Honda K, Nomiya M. Neurourol Urodyn. 26(s6): 904–7, October 2007.
30. Wein AJ. Urgency: The cornerstone symptom of overactive bladder. J Urol 2005; 173: 2054.

________________________________________________

1. Abrams P, Wein AJ. The overactive bladder: from basic science to clinical management. Urology 1997; 50 (Suppl. 6A): 1–144.
2. Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–36.
3. Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760–6.
4. Liberman JN, Hunt TL, Stewart WF et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. communitybased survey. Urology 2001; 57: 1044–50.
5. Zinner N, Noe L, Rasouliyan L et al. Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Curr Med Res Opin 2008 Apr 17.
6. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78.
7. Chapple CR, Artibani W, Cardozo LD et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: Current concepts and future prospects. BJU Int 2005; 95: 335–40.
8. Athwal BS, Berkley KJ, Hussain I et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain 2001; 124: 369–77.
9. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997; 50: 36–52.
10. Drake MJ, Harvey IJ, Gillespie JI et al. Localized contractions in the normal human bladder and in urinary urgency. BJU Int 2005; 95: 1002–5.
11. Turner WH, Brading AF. Smooth muscle of the bladder in the normal and the diseased state: Pathophysiology, diagnosis and treatment. Pharmacol Ther 1997; 75: 77–110.
12. Coolsaet BL, Van Duyl WA, Van Os-Bossagh P et al. New concepts in relation to urge and detrusor activity. Neurourol Urodyn 1993; 12: 463–71.
13. de Groat WC. The urothelium in overactive bladder: Passive bystander or active participant? Urology 2004; 64: 7–11.
14. Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001; 358: 401–3.
15. Brubaker L. Urinary urgency and frequency: What should a clinician do? Obstet Gynecol 2005; 105: 661–7.
16. Greenberg P, Brown J, Yates T et al. Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol Urodyn 2008; 27 (4): 287–90.
17. Abrams P. Urgency the key to defining the overactive bladder. BJU Int 2005; 96: 1–3.
18. Barber MD. Questionnaires for women with pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 461–5.
19. Abrams P, Artibani W, Cardozo L et al. Reviewing the ICS 2002 Terminology Report: The Ongoing Debate. Neurourol Urodyn 2006; 25: 293.
20. European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence in Women. November 2001.
21. Cardozo L, Coyne KS, Versi E. Validation of the urgency perception scale. BJU Int 2005; 95: 591–6.
22. Blaivas JG, Panagopoulos G, Weiss JP et al. The urgency perception score: Validation and test–retest. J Urol 2007; 177: 199–202.
23. Blaivas JG, Panagopoulos G, Weiss JP et al. The urgency perception score: Validation and test–retest. J Urol 2007; 177: 199–202.
24. Nixon A, Colman S, Sabounjian L et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005; 174: 604–7.
25. Lukacz ES, Lawrence JM, Burchette RJ et al. The use of Visual Analog Scale in urogynecologic research: A psychometric evaluation. Am J Obstet Gynecol 2004; 191: 165–70.
26. Coyne K, Matza LS, Versi E. Urinary urgency: Can "'gotta go'" be measured? Poster presented at the 10th Annual Meeting of the International Society for Quality of Life Research, Prague, Czech Republic, 2003.
27. Freeman RM. How urgent is urgency? A review of current methods of assessment. Int Urogynecol J Pelvic Floor Dysfunct 2005; 16: 93–5.
28. Zinner N, Harnett M, Sabounjian L et al. The overactive bladder-symptom composite score: A composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 2005; 173: 1639–43.
29. Yamaguchi O, Honda K, Nomiya M. Neurourol Urodyn. 26(s6): 904–7, October 2007.
30. Wein AJ. Urgency: The cornerstone symptom of overactive bladder. J Urol 2005; 173: 2054.

Д.Ю.Пушкарь, А.В.Зайцев, П.И.Раснер, Г.Р.Касян

Кафедра урологии Московского государственного медико-стоматологического университета 
(зав. кафедрой – докт. мед. наук проф. Д.Ю.Пушкарь)